Profiling guselkumab super responders in Chinese patients with moderate-to-severe psoriasis: Insights from a phase 4 RCT post-hoc analysis

Abrocitinib achieves rapid and sustained symptom control in AD: Results from the 2^nd interim analysis of the AHEAD study

Psoriasis associated with increased risk of AMD: Evidence from a retrospective observational cohort study

AD linked to elevated suicidal ideation risk: Insights from a global epidemiology study